Docetaxel

9 registered clinical trials studyying Docetaxel — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer NCT07366528	Ruijin Hospital	Phase 3
Not Yet Recruiting	Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive B NCT06374914	Dokuz Eylul University	—
Completed	A Bioequivalence Study of Docetaxel Injection in Patients With Solid Tumours NCT04889599	Zhuhai Beihai Biotech Co., Ltd	Phase 3
Completed	Interest of the Addition of Docetaxel to Standard Treatment in First-line Advanced HER2 Positive Gastroesophag NCT04920747	Centre Hospitalier Universitaire de Besancon	—
Unknown	A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC NCT04023617	Peking University Cancer Hospital & Institute	Phase 2
Unknown	FOLFIRINOX vs FLOT Chemotherapy for Resectable Gastric or Esophagogastric Junction Adenocarcinoma NCT04393584	Blokhin's Russian Cancer Research Center	Phase 2 / Phase 3
Unknown	Anlotinib Plus Chemotherapy for Patients With Advanced Non-small Cell Lung Cancer NCT03589950	The First People's Hospital of Lianyungang	Phase 2
Unknown	Association of Genetic Polymorphisms With Docetaxel-based Chemotherapy Toxicities in Chinese Solid Tumor Patie NCT03258151	Cui Yimin	—
Unknown	PROSTAC: Prospective Multi-centre Study of Prognostic Factors in mCRPC Patients Treated With Docetaxel or Caba NCT02362620	Centro Nacional de Investigaciones Oncologicas CARLOS III	—